Rogers Sugar (RSI) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
1 Feb, 2026Executive summary
Q3 2024 was the most profitable third quarter in company history, with record adjusted EBITDA of $34.5M, up $10.7M year-over-year, driven by strong Sugar and Maple segment performance and favorable market trends.
Revenues rose to $309.1M in Q3 2024, a $46.8M increase from Q3 2023, mainly due to higher pricing in Sugar and Maple segments.
The company is executing its Rogers Refined plan, focusing on modernizing sugar operations, driving maple profitability, maintaining a strong balance sheet, and advancing ESG initiatives.
Adjusted net earnings per share reached $0.13, up $0.05 from the prior year quarter.
Free cash flow for the trailing twelve months was $74.5M, up $26.7M year-over-year.
Financial highlights
Consolidated revenues reached $309.1M, up nearly 18% year-over-year, with double-digit growth in both sugar and maple.
Q3 2024 adjusted EBITDA was $34.5M, a 45% increase from last year; year-to-date adjusted EBITDA surpassed $100M for the first time.
Adjusted net earnings for Q3 were $16.3M ($0.13 per share), up from $8.7M ($0.08 per share) last year.
Free cash flow for the twelve months ended June 2024 was $74.5M, up more than 50% year-over-year.
Dividend of $0.09 per share declared for Q3 2024.
Outlook and guidance
Expecting another record year in fiscal 2024, with strong contributions from both segments and continued growth in adjusted EBITDA.
Sugar segment adjusted EBITDA is projected to increase despite earlier labor disruptions and a slight decline in domestic sales.
Maple segment is expected to maintain strong results, benefiting from a healthy crop, price increases, automation, and operational improvements.
Margins in sugar are expected to stabilize at current strong levels, with future variation driven by customer mix.
Regular capital spending for 2024 estimated at $28M, excluding LEAP Project expenditures.
Latest events from Rogers Sugar
- Q1 2026 saw higher earnings and margins, strong free cash flow, and LEAP project progress.RSI
Q1 20265 Feb 2026 - Record financial results, all motions passed, and LEAP Project advances for future growth.RSI
AGM 20264 Feb 2026 - Record 2024 results, 25–28% EBITDA growth, LEAP costs rise, 2025 outlook strong.RSI
Q4 202412 Jan 2026 - Record 2024 results, LEAP expansion progress, and all motions passed amid trade policy risks.RSI
AGM 20256 Jan 2026 - Q1 2025 adjusted EBITDA up 29% with double-digit revenue growth and strong segment performance.RSI
Q1 202516 Dec 2025 - Record FY2025 profit, LEAP Project delayed to 2027, and free cash flow up to $104M.RSI
Q4 202527 Nov 2025 - Strong sugar and maple growth drove higher EBITDA, with LEAP project and dividend stability.RSI
Q3 202523 Nov 2025 - Record Maple results and strong Sugar demand drive growth despite US tariff uncertainty.RSI
Q2 202518 Nov 2025